Premium Pharma SRL
Premium Pharma reported total assets of 55,853 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Sep 2026).
The score of Premium Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -92 % Total assets -81 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Premium Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Sep 2026
- Year ended 31 Dec 2024filed on 31 Oct 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 30 Jun 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
Premium Pharma's financial analysis
- Solvency4.5%sector median: 44.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Premium Pharma
Premium Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0896.401.843
- VAT number
- BE0896401843
- Peppol
- Registered · 0208:0896401843 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 12 Mar 2008
- Registered office
- 1050 Ixelles
- Latest accounts
- 2025 · filed on 29 Sep 2026
- Activity
- Organisation of conventions and trade shows (NACE 82300)
Premium Pharma (SRL) has been based in Ixelles since 2008, active in: organisation of conventions and trade shows. For 2025, it reports a net loss of 15,104 € and equity of 2,501 €; its revenue is not published. Its solvency stands at 4.5%, below the median of its sector (44.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Premium Pharma
Companies in the same business, of comparable size and area, outside its group.
- BYG Organisation of conventions and trade shows Woluwe-Saint-Pierre · balance sheet 59,041 €
- JACH Consult Organisation of conventions and trade shows Uccle · balance sheet 118,995 €
- Eurava Media & Production Activities of advertising agencies Brussels · balance sheet 40,676 €
- Chili CON Carne Organisation of conventions and trade shows Ixelles · balance sheet 46,283 €
- Eurokids' Team Organisation of conventions and trade shows Brussels · balance sheet 92,612 €
- St. Antoine Organisation of conventions and trade shows Dilbeek · balance sheet 123,943 €
- Atelier de l'Imagier - Tinygallery Organisation of conventions and trade shows Etterbeek · balance sheet 123,659 €
- Yaka Factory Organisation of conventions and trade shows Ixelles · balance sheet 162,433 €
Frequently asked questions about Premium Pharma
What is the revenue of Premium Pharma?
Premium Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Premium Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0896401843 for Premium Pharma, if the company is VAT-registered. Its company number (CBE) is 0896.401.843.
Where is the registered office of Premium Pharma?
According to the CBE register, the registered office of Premium Pharma is in 1050 Ixelles.
What is the equity of Premium Pharma?
At the close of the 2025 financial year, the equity of Premium Pharma amounts to 2,501 €, a solvency of 4.5% of total assets.
Who manages Premium Pharma?
The register lists 1 active mandates at Premium Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Premium Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →